2-(5-Bromo-pyridin-3-yl)-5-[3-(4,5,6,7-tetra-hydro-thieno[3,2-c]pyridine-5-ylsulfon-yl)thio-phen-2-yl]-1,3,4-oxa-diazole
- PMID: 22058804
- PMCID: PMC3201536
- DOI: 10.1107/S1600536811038529
2-(5-Bromo-pyridin-3-yl)-5-[3-(4,5,6,7-tetra-hydro-thieno[3,2-c]pyridine-5-ylsulfon-yl)thio-phen-2-yl]-1,3,4-oxa-diazole
Abstract
In the title compound, C(18)H(13)BrN(4)O(3)S(3), the tetra-hydro-pyridine ring adopts a half-chair conformation with the central methyl-ene-C atom of the NCH(2)CH(2) unit at the flap. The dihedral angles between the tetra-hydro-pyridine ring and the pyridine and two thio-phene rings are 69.34 (13) 5.66 (13) and 68.63 (13)°, respectively, while the dihedral angle between the 1,3,4-oxadiazole and tetra-hydro-pyridine rings is 54.76 (13)°. The mol-ecule is stabilized by an intra-molecular C-H⋯N inter-action. In the crystal, adjacent mol-ecules are connected via bifurcated C-H⋯(N,O) hydrogen bonds, forming a chain along the b axis.
Figures
References
-
- Bruker (2009). APEX2, SAINT and SADABS Bruker AXS Inc., Madison, Wisconsin, USA.
-
- Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc 97, 1354–1358.
-
- Lopez-Rodriguez, M. L., Murcia, M., Benhamu, B., Viso, A., Campillo, M. & Pardo, L. (2001). Bioorg. Med. Chem. Lett. 11, 2807–2811. - PubMed
-
- Roth, B. L., Craigo, S. C., Choudhary, M. S., Uluer, A., Monsma, F. J. Jr, Shen, Y., Meltzer, H. Y. & Sibley, D. R. (1994). J. Pharm. Exp. Ther. 268, 1403–1410. - PubMed
-
- Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases